Nichols TC - Search Results

1

Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy.

Herzog RW, Fields PA, Arruda VR, Brubaker JO, Armstrong E, McClintock D, Bellinger DA, Couto LB, Nichols TC, High KA. Herzog RW, et al. Among authors: nichols tc. Hum Gene Ther. 2002 Jul 20;13(11):1281-91. doi: 10.1089/104303402760128513. Hum Gene Ther. 2002. PMID: 12162811

2

von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis.

Brinkhous KM, Reddick RL, Read MS, Nichols TC, Bellinger DA, Griggs TR. Brinkhous KM, et al. Among authors: nichols tc. Mayo Clin Proc. 1991 Jul;66(7):733-42. doi: 10.1016/s0025-6196(12)62087-4. Mayo Clin Proc. 1991. PMID: 2072761 Review.

3

Coronary atherosclerosis in the pig. Induced plaque injury and platelet response.

Reddick RL, Read MS, Brinkhous KM, Bellinger D, Nichols T, Griggs TR. Reddick RL, et al. Arteriosclerosis. 1990 Jul-Aug;10(4):541-50. doi: 10.1161/01.atv.10.4.541. Arteriosclerosis. 1990. PMID: 2369365

4

Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.

Bellinger DA, Nichols TC, Read MS, Reddick RL, Lamb MA, Brinkhous KM, Evatt BL, Griggs TR. Bellinger DA, et al. Among authors: nichols tc. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8100-4. doi: 10.1073/pnas.84.22.8100. Proc Natl Acad Sci U S A. 1987. PMID: 3120185 Free PMC article.

5

Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion.

Read MS, Reddick RL, Bode AP, Bellinger DA, Nichols TC, Taylor K, Smith SV, McMahon DK, Griggs TR, Brinkhous KM. Read MS, et al. Among authors: nichols tc. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):397-401. doi: 10.1073/pnas.92.2.397. Proc Natl Acad Sci U S A. 1995. PMID: 7831298 Free PMC article.

6

Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia.

Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE. Monahan PE, et al. Among authors: nichols tc. Gene Ther. 1998 Jan;5(1):40-9. doi: 10.1038/sj.gt.3300548. Gene Ther. 1998. PMID: 9536263

7

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector.

Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA. Herzog RW, et al. Among authors: nichols tc. Nat Med. 1999 Jan;5(1):56-63. doi: 10.1038/4743. Nat Med. 1999. PMID: 9883840

8

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors.

Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin HF, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA. Snyder RO, et al. Nat Med. 1999 Jan;5(1):64-70. doi: 10.1038/4751. Nat Med. 1999. PMID: 9883841

9

Persistent expression of canine factor IX in hemophilia B canines.

Chao H, Samulski R, Bellinger D, Monahan P, Nichols T, Walsh C. Chao H, et al. Gene Ther. 1999 Oct;6(10):1695-704. doi: 10.1038/sj.gt.3301024. Gene Ther. 1999. PMID: 10516718

10

Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling.

Nichols TC, du Laney T, Zheng B, Bellinger DA, Nickols GA, Engleman W, Clemmons DR. Nichols TC, et al. Circ Res. 1999 Nov 26;85(11):1040-5. doi: 10.1161/01.res.85.11.1040. Circ Res. 1999. PMID: 10571535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters